13.54

1.18% 0.010

Mediwound Ltd (MDWD)

Overview News Price History Option Chain Discussions Forecast Stock Split

Mediwound Ltd stock is traded at $13.54, with a volume of 8,777. It is up +1.18% in the last 24 hours and down -3.93% over the past month. MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Previous Close:

$13.53

Open:

$13.52

24h Volume:

8,777

Relative Volume:

0.10

Market Cap:

$173.57M

Revenue:

$14.48M

Net Income/Loss:

$-26.11M

P/E Ratio:

-5.9935

EPS:

-2.2591

Net Cash Flow:

$-23.86M

1W Performance:

-4.86%

1M Performance:

-3.93%

6M Performance:

-20.73%

1Y Performance:

-26.28%

1-Day Range:

$13.40

$13.69

1-Week Range:

$13.40

$14.53

52-Week Range:

$13.40

$20.30

Mediwound Ltd Stock (MDWD) Company Profile

Name

Mediwound Ltd

Sector

Healthcare (1083)

Industry

Biotechnology (601)

Phone

Address

Employee

121

Twitter

Next Earnings Date

2026-08-13

Latest SEC Filings

MDWD's Discussions on Twitter

Compare MDWD vs VRTX, REGN, ARGX, RVMD, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MDWD Mediwound Ltd	13.51	178.77M	14.48M	-26.11M	-23.86M	-2.2591
VRTX Vertex Pharmaceuticals Inc	505.21	133.25B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	799.02	82.16B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	839.99	54.80B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	200.86	43.99B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	346.40	40.62B	5.76B	514.49M	1.10B	4.4813

Mediwound Ltd Stock (MDWD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-02-25	Resumed	Oppenheimer	Outperform
May-02-25	Initiated	Alliance Global Partners	Buy
Feb-28-25	Initiated	Craig Hallum	Buy
Jul-16-24	Reiterated	Maxim Group	Buy
Dec-22-22	Initiated	Maxim Group	Buy
Jul-18-22	Resumed	Oppenheimer	Outperform
Sep-23-20	Initiated	BTIG Research	Buy
Nov-28-16	Initiated	Aegis Capital	Buy
Aug-17-16	Initiated	Wells Fargo	Outperform
Apr-16-14	Initiated	Oppenheimer	Outperform

View All

Mediwound Ltd Stock (MDWD) Latest News

03:14 AM

Key facts: MediWound Ltd. (MDWD) Q2 $3.09M rev; EscharEx $4B target - TradingView

03:14 AM

Mediwound Ltd (MDWD)

Mediwound Ltd Stock (MDWD) Company Profile

Compare MDWD vs VRTX, REGN, ARGX, RVMD, ONC

Mediwound Ltd Stock (MDWD) Upgrades & Downgrades

Mediwound Ltd Stock (MDWD) Latest News

Key facts: MediWound Ltd. (MDWD) Q2 $3.09M rev; EscharEx $4B target - TradingView

Q2 2026 Mediwound Ltd Earnings Call Transcript - GuruFocus

MediWound (NASDAQ:MDWD) Issues Earnings Results - MarketBeat

MediWound Ltd (MDWD) (Q2 2026) Earnings Call Highlights: Record - GuruFocus

MediWound Ltd (MDWD) (Q2 2026) Earnings Call Highlights: Record NexoBrid Sales and EscharEx ... - Yahoo! Finance Canada

A. G. P. Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $22 - Moomoo

MediWound Q2 2026 Earnings Call Transcript - MarketBeat

MediWound Q2 Earnings Call Highlights - MarketBeat

Earnings call transcript: MediWound tops Q2 2026 revenue forecast as shares rise - Investing.com

MediWound Q2 2026 Earnings Call: Complete Transcript - Benzinga

Mediwound Ltd reports results for the quarter ended June 30Earnings Summary - TradingView

Mediwound Ltd. Reaffirms Revenue Guidance for the Full-Year 2026 - marketscreener.com

MediWound Q2 Results: Sales beat estimates, EPS miss widens - scanx.trade

MediWound Ltd. (MDWD) Q2 FY2026 earnings call transcript - Yahoo Finance

MediWound (MDWD) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance

MediWound Q2 2026 Results Highlight EscharEx Trial Progress and New NexoBrid BARDA Agreement - TipRanks

MEDIWOUND ($MDWD) Releases Q2 2026 Earnings - Quiver Quantitative

MediWound: Q2 Earnings Snapshot - Yahoo Finance

MediWound (NASDAQ: MDWD) revenue drops in H1 2026 but guidance held - Stock Titan

MediWound's Phase III Wound Trial Targets 216 Patients at About 40 Sites - Stock Titan

Technical Reactions to MDWD Trends in Macro Strategies - Stock Traders Daily

Mediwound Ltd (MDWD) Stock News Today - TradingKey

Mediwound Ltd (MDWD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

MediWound (NASDAQ:MDWD) Stock Price Crosses Below 200-Day Moving AverageHere's What Happened - MarketBeat

MediWound (MDWD) Expected to Release Earnings on Thursday - MarketBeat

MediWound Ltd. Revenue Breakdown – FWB:M8W - TradingView

Trading the Move, Not the Narrative: (MDWD) Edition - Stock Traders Daily

MediWound to Report Second Quarter 2026 Financial Results - GlobeNewswire

MediWound Schedules August 13 Webcast for Second-Quarter Results - Stock Titan

MDWD|Mediwound Ltd|Price:14.500|Chg%:+0.270 - TradingKey

MediWound Ltd. Revenue Breakdown – BOATS:MDWD - TradingView

Mediwound Ltd (MDWD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

MDWD Q1 2026 Earnings: Significant Earnings Beat Despite Revenue AbsenceSpecial Dividend Alert - dars.gov.et

Mediwound Ltd (MDWD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Mediwound Ltd (MDWD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Mediwound Ltd (MDWD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

TradingKey - TradingKey

MDWD|Mediwound Ltd|Price:14.230|Chg%:-0.040 - TradingKey

Mediwound Ltd (MDWD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

MediWound Ltd. Announces $30 Million Registered Direct Offering of Ordinary Shares - Quiver Quantitative

(MDWD) Volatility Zones as Tactical Triggers - Stock Traders Daily

Why is Cathie Wood’s ARK Fund Backing this Israeli Innovator? (NASDAQ: MDWD) - The Globe and Mail

MediWound Ltd. (MDWD) Q1 2026 Earnings: EPS Surprise Beats Estimates Despite Narrow LossCore Business Growth - dars.gov.et

MDWD Q1 2026 Earnings: Strong EPS Beat Highlights Operational ProgressEnergy Earnings Report - dars.gov.et

MediWound Ltd. (MDWD) Q1 2026 Earnings: Narrowed Loss Beats Expectations, but Stock SlipsFiscal Year Earnings - DonanımHaber

MDWD Q1 2026 Earnings: EPS Surprise of 65.5% Signals Narrower LossesEPS Estimate Trend - po-news-eg.net

Enterprise value to EBITDA forward of MediWound Ltd. – NASDAQ:MDWD - TradingView

MediWound (MDWD) Stock Analysis Report | Ratings, Financials & Performance - Benzinga España

MDWDMediWound Ltd Volatility & Greeks - Finviz

Enterprise value to revenue forward of MediWound Ltd. – FWB:M8W - TradingView

MediWound Ltd.(NasdaqGM: MDWD) added to Russell 2000 Value-Defensive Index - marketscreener.com

Mediwound Ltd Stock (MDWD) Financials Data

Revenue

Net Income

Cash Flow

EPS

Similar to MDWD